{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Medico Intercontinental Ltd
Medico Intercontinental Falls to 52-Week Low of Rs.29.3 Amid Market Volatility
Medico Intercontinental's stock price reached a fresh 52-week low of Rs.29.3 today, marking a significant decline amid a volatile trading session. The stock's performance contrasts sharply with broader market gains, reflecting ongoing pressures within the company’s financials and sector dynamics.
Is Medico Intercon. overvalued or undervalued?
As of November 17, 2025, Medico Intercon. is considered very expensive with a PE ratio of 3266.00, significantly higher than its peers, and has underperformed the market with a year-to-date return of -40.18%.
How has been the historical performance of Medico Intercon.?
Medico Intercon has shown significant growth in net sales and profitability, with net sales increasing from 10.30 Cr in Mar'19 to 95.32 Cr in Mar'25, and profit after tax rising from 0.74 Cr to 4.96 Cr. However, the company faced cash flow challenges in the latest fiscal year, reporting a negative cash flow of -7.00 Cr in Mar'25.
Medico Intercontinental Stock Plummets to New 52-Week Low at Rs.30
Medico Intercontinental has hit a new 52-week low, reflecting a significant decline in its stock performance. Over the past year, the company has experienced a 20.04% decrease in stock value, alongside a drop in profit before tax and net sales, indicating ongoing financial challenges.
Medico Intercontinental Hits New 52-Week Low at Rs.30 Amid Market Struggles
Medico Intercontinental has hit a new 52-week low, reflecting a significant decline in its stock performance. Over the past year, the company has experienced a notable drop, contrasting with broader market gains. Financial metrics indicate challenges, including a decline in profit before tax and net sales.
When is the next results date for Medico Intercon.?
The next results date for Medico Intercon is 14 November 2025.
Medico Intercontinental Faces Significant Volatility Amid Broader Market Resilience
Medico Intercontinental, a microcap in the Trading & Distributors sector, has faced significant volatility, reaching a new 52-week low. The stock has underperformed its sector and broader market indices, with a notable decline in net sales and profit after tax, highlighting ongoing financial challenges.
Medico Intercontinental Faces Financial Challenges Amidst Declining Profitability and Sales
Medico Intercontinental, a microcap in the Trading & Distributors sector, has reported a challenging financial quarter ending June 2025. Despite a 21.53% growth in net sales over six months, the company faces significant hurdles, including a decline in profit after tax and key profitability metrics, alongside a poor year-to-date price performance.
How has been the historical performance of Medico Intercon.?
Medico Intercon has shown significant growth in net sales and profitability, with net sales increasing from 10.30 Cr in Mar'19 to 95.32 Cr in Mar'25, and profit after tax rising from 0.74 Cr to 4.96 Cr in the same period, reflecting enhanced operational efficiency and a solid balance sheet.
Are Medico Intercon. latest results good or bad?
Medico Intercontinental's latest results are concerning, with a Profit Before Tax of Rs -2.27 crore and a decline in net sales by 11.8% to Rs 21.35 crore, indicating significant financial challenges. The company's profitability and operating margins have also decreased, reflecting a troubling trend.
Medico Intercontinental Reports Decline in Key Financial Metrics for June 2025
Medico Intercontinental has reported its financial results for the quarter ending June 2025, revealing a challenging period. Key metrics show declines in profit before tax, profit after tax, and net sales, alongside a decrease in operating profit and margin. The company's debt-equity ratio has also increased, indicating higher borrowing levels.
Medico Intercontinental Hits 52-Week Low Amidst High Volatility and Sector Underperformance
Medico Intercontinental, a microcap in the Trading & Distributors sector, reached a new 52-week low today, reflecting significant volatility. Despite a 24.96% decline over the past year, the company reported a profit after tax of Rs. 3.97 crore for the nine-month period ending March 25, indicating growth.
When is the next results date for Medico Intercon.?
Medico Intercon. will announce its results on 14 August 2025.
How has been the historical performance of Medico Intercon.?
Medico Intercon has shown steady growth in net sales and profitability, with net sales increasing from 10.30 Cr in Mar'19 to 96.02 Cr in Mar'25, and profit after tax rising from 0.74 Cr to 5.06 Cr during the same period. The company's total assets also grew significantly, reflecting its expanding operations.
Medico Intercontinental Reports Profit Growth Amid Long-Term Market Challenges
Medico Intercontinental, a microcap in the Trading & Distributors sector, recently experienced an evaluation adjustment reflecting its market position. The company reported a 35.49% increase in profit after tax for the first nine months and a 35.36% rise in net sales, despite facing long-term fundamental challenges.
How has been the historical performance of Medico Intercon.?
Medico Intercon has demonstrated strong historical performance, with net sales increasing from 10.30 Cr in March 2019 to 96.02 Cr in March 2025, and a net profit of 5.06 Cr for the same period, reflecting effective cost management and consistent profitability growth.
How big is Medico Intercon.?
As of 24th July, Medico Intercontinental Ltd has a market capitalization of 39.00 Cr, with recent Net Sales of 96.01 Cr and a Net Profit of 5.05 Cr. The company's Shareholder's Funds are 45.03 Cr and Total Assets are 56.04 Cr as of March 2024.
What does Medico Intercon. do?
Medico Intercontinental Ltd, incorporated in 1984, trades pharmaceutical products and operates as a Micro Cap company with recent net sales of 214 Cr and a net profit of 12 Cr as of March 2025. The company has a market cap of INR 39 Cr and key financial metrics include a P/E of 8.00 and a return on equity of 10.38%.
Who are the top shareholders of the Medico Intercon.?
The top shareholder of Medico Intercon is Shah Samir, holding 44.43% of shares, with no pledged promoter holdings. Individual investors own 39.51%, and the highest public shareholder is Lalita at 1.5%.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
